← FDA Drug Approvals (Drugs@FDA)

ERYTHRA-DERM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MICRO LABS · Approved 1988-02-05

Drug application

FDA Application #

ANDA062687

Application type

Abbreviated New Drug Application (Generic)

Brand name

ERYTHRA-DERM

Generic name

ERYTHROMYCIN TOPICAL SOLUTION 2%

Active ingredients

ERYTHROMYCIN

Dosage form

SOLUTION

Route

TOPICAL

Marketing status

Prescription

Sponsor

MICRO LABS

Manufacturer

Saptalis Pharmaceuticals, LLC LLC

First approval

1988-02-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown